Terms: = Ovarian cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Diagnosis
6 results:
1. Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer.
Galdiero F; Romano A; Pasquinelli R; Pignata S; Greggi S; Vuttariello E; Bello AM; Calise C; Scaffa C; Pisano C; Losito NS; Fusco A; Califano D; Chiappetta G
Oncotarget; 2015 Aug; 6(22):19328-35. PubMed ID: 25749380
[TBL] [Abstract] [Full Text] [Related]
2. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.
Davidson B; Holth A; Hellesylt E; Tan TZ; Huang RY; Tropé C; Nesland JM; Thiery JP
Hum Pathol; 2015 Jan; 46(1):1-8. PubMed ID: 25455994
[TBL] [Abstract] [Full Text] [Related]
3. Anti-miR182 reduces ovarian cancer burden, invasion, and metastasis: an in vivo study in orthotopic xenografts of nude mice.
Xu X; Ayub B; Liu Z; Serna VA; Qiang W; Liu Y; Hernando E; Zabludoff S; Kurita T; Kong B; Wei JJ
Mol Cancer Ther; 2014 Jul; 13(7):1729-39. PubMed ID: 24825857
[TBL] [Abstract] [Full Text] [Related]
4. hmga2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
McCluggage WG; Connolly LE; McBride HA; Kalloger S; Gilks CB
Histopathology; 2012 Mar; 60(4):547-53. PubMed ID: 22250726
[TBL] [Abstract] [Full Text] [Related]
5. Gynecologic malignancies in women aged less than 25 years.
You W; Dainty LA; Rose GS; Krivak T; McHale MT; Olsen CH; Elkas JC
Obstet Gynecol; 2005 Jun; 105(6):1405-9. PubMed ID: 15932836
[TBL] [Abstract] [Full Text] [Related]
6. Recent advances in immunohistochemistry in gynaecological pathology.
McCluggage WG
Histopathology; 2002 Apr; 40(4):309-26. PubMed ID: 11943015
[TBL] [Abstract] [Full Text] [Related]
